ProgramsA focused pipeline
A focused pipeline
for durable cures.
We are advancing a portfolio of CRISPR-based investigational therapies against viral diseases where persistence remains the central challenge.
Our approach
Start with the biology. Scale with discipline.
Each program is built around a clear viral target, a defined patient need and a development path that balances ambition with evidence.
CodeProgramIndicationStage
EBT-101
HIV cure research
HIV-1 infectionClinical research↗EBT-201
Viral reservoir program
Chronic viral diseasePreclinical↗EBT-301
Next-generation editing
Emerging targetsDiscovery↗Development path
Every milestone is a promise to keep testing.
Define the target
Map the viral reservoir and identify sequences where precision editing could have the greatest therapeutic value.
Prove the mechanism
Test editing, selectivity and durability in a cascade of models designed to answer the hard questions early.
Translate to patients
Move with care into clinical development, measuring the outcomes that matter to people—not just to assays.
Stay informed
Progress worth following.
Read the latest updates from our research, leadership and company.
Read the news ↗